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 • MUSCULOSKELETAL IMAGING
After lower back pain, knee pain is the most commonly reported musculoskeletal reason for patients to visit 
their general practitioner (GP) (1,2). Among these pa-
tients are those with knee pain due to trauma, which has 
a substantial effect on quality of life, especially in younger 
patients (3). The estimated incidence of new knee injuries 
ranges from one to two cases per 1000 patients per year, 
with a peak incidence of four to six cases per 1000 patients 
per year in patients aged 15–25 years (2,4).
Magnetic resonance (MR) imaging is the modality of 
choice in the diagnosis of a soft-tissue lesion, with a sensi-
tivity of 87% and a specificity of 93% in the overall detec-
tion of meniscus and anterior cruciate ligament tears (5,6). 
The high diagnostic accuracy of MR imaging made diag-
nostic arthroscopy obsolete and justified the use of MR 
imaging to make a diagnosis after knee trauma (5).
Although the majority of knee MR examinations are 
still requested by orthopedic surgeons (with well-estab-
lished added value), in the past decade, a shift toward ear-
lier MR imaging in primary care has been seen (7,8). The 
suggested potential beneficial effects of MR imaging in 
primary care are as follows: In case of negative findings, pa-
tients can be reassured and might be able to avoid unneces-
sary referrals to secondary care. In case of positive findings, 
an earlier diagnosis can be made, potentially resulting in 
earlier recovery (9–14).
However, due to the lack of evidence regarding the 
added value of MR imaging in primary care, the Dutch 
College of General Practitioners guidelines (15) recom-
mend not to request MR imaging in these patients. Other 
countries have developed similar guidelines that provide 
conflicting or unclear advice regarding when to perform 
MR imaging in primary care or when to refer to a patient 
to an orthopedic surgeon (5,16–18).
The aim of this study was to determine the cost- 
effectiveness of early referral by the GP for MR imaging 
compared with usual care alone in patients with traumatic 
knee symptoms over a 1-year period.
Materials and Methods
All patients approved and signed the informed consent 
form before entering this study. The study was approved 
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Purpose: To determine the cost-effectiveness of early referral by the general practitioner for magnetic resonance (MR) imaging 
compared with usual care alone in patients aged 18–45 years with traumatic knee symptoms.
Materials and Methods: Cost-utility analysis was performed parallel to a prospective multicenter randomized controlled trial in 
Dutch general practice. A total of 356 patients with traumatic knee symptoms were included from November 2012 to December 
2015 (mean age, 33 years 6 8 [standard deviation]; 222 men [62%]). Patients were randomly assigned to usual care (n = 177; MR 
imaging was not performed, but patients were referred to an orthopedic surgeon when conservative treatment was unsatisfactory) 
or MR imaging (n = 179) within 2 weeks after injury. Main outcome measures were quality-adjusted life years (QALYs) and costs 
from a healthcare and societal perspective. Multiple imputation was used for missing data. The Student t test was used to assess dif-
ferences in mean QALYs, costs, and net benefits.
Results: Mean QALYs were 0.888 in the MR imaging group and 0.899 in the usual care group (P = .255). Healthcare costs per  
patient were higher in the MR imaging group (€1109) than in the usual care group (€837) (P = .050), mainly due to higher costs 
for MR imaging, with no reduction in the number of referrals to an orthopedic surgeon in the MR imaging group.
Conclusion: MR imaging referral by the general practitioner was not cost-effective in patients with traumatic knee symptoms; in 
fact, MR imaging led to more healthcare costs, without an improvement in health outcomes.
© RSNA, 2018
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Abbreviations
GP = general practitioner, QALY = quality-adjusted life year, WTP = 
willingness to pay
Summary
In this randomized controlled trial, MR imaging referral by the gen-
eral practitioner was not cost-effective in patients aged 18–45 years with 
traumatic knee injury. MR imaging led to more healthcare costs but did 
not improve health outcomes.
Implications for Patient Care
 n Early MR imaging in general practice did not improve health 
outcomes, reduce orthopedic referral, or reduce arthroscopy rate in 
patients aged 18–45 years with traumatic knee symptoms.
 n Usual care (no routine referral to MR imaging; instead, referral 
to an orthopedic surgeon in case of persistent knee symptoms) 
should remain the guideline for patients aged 18–45 years with 
traumatic knee symptoms who visit their general practitioner.
by the medical ethics committee of the Erasmus Medical Center 
and by the Dutch National Central Committee on Research In-
volving Human Subjects (Dutch trial registration, NTR3689).
Study Design and Patients
We conducted an economic evaluation parallel to a prospec-
tive pragmatic multicenter open-labeled noninferiority ran-
domized controlled trial with 12 months of follow-up. Details 
of the research protocol already have been published (9). We 
chose a noninferiority design, since MR imaging was regarded 
as a newly introduced diagnostic tool in general practice. The 
study was powered to detect this noninferiority (9). From Oc-
tober 2012 to December 2015, patients aged 18–45 years who 
consulted or reconsulted their GP with knee symptoms due 
to a traumatic injury or a sudden onset of pain, function loss, 
or both in the preceding 6 months were included. The age 
criterion (45 years) was chosen to exclude subjects with a 
relatively higher prevalence of degenerative findings for which 
no clear treatment options are currently available, meaning the 
MR findings would have had little influence on subsequent 
treatment. Exclusion criteria were indications for direct referral 
(eg, a fracture or a locked knee), patients already in secondary 
care for their current knee symptoms, previous surgery in the 
affected knee, knee osteoarthritis diagnosed earlier by a physi-
cian, other nontraumatic arthropathy (eg, isolated patellofem-
oral pain or patella luxation), a previous MR examination 
for current knee symptoms, and contraindications to MR 
imaging. When a patient again consulted the GP with persis-
tent knee symptoms and was not invited to participate during 
the first visit, the patient was only eligible for inclusion when 
the performed diagnostics and treatment adhered to Dutch 
guidelines after the first consultation, without MR imaging 
or an orthopedic referral. These patients still experienced 
symptoms of traumatic knee injury but usually had a longer 
history of symptoms. A total of 150 GPs located in the west-
ern part of the Netherlands invited all the patients included 
in this trial directly during consultation or afterward by send-
ing invitation letters to eligible patients who were missed dur-
ing the first consultation.
Randomization and Subject Group
After the patients signed the informed consent form and com-
pleted the first questionnaire, the researchers (K.v.O., N.M.S.) 
performed the randomization. An independent person produced 
a randomization list with a computer by using random blocks of 
four and six without stratifying for patient characteristics. The 
researchers had no access to the randomization list, resulting in 
a concealed allocation that could not be predicted or influenced. 
A total of 356 patients (mean age, 33 years 6 8 [standard de-
viation]; age range, 18–45 years) were included and randomly 
assigned to one of the groups. Of these patients, 222 (62%) were 
male, with a mean age of 32 years 6 8 (range, 18–45 years), and 
134 were female (38%; mean age, 33 years 6 8; range, 18–45 
years). Mean duration of symptoms was 52 days 6 44.
Patients were evenly allocated to undergo either usual care 
or MR imaging, and no patient or caregiver was blinded to 
group assignment (Fig 1). Patients in the usual care group were 
treated by the GP according to Dutch clinical guidelines (15), 
which provide advice on (a) whether rest or specific exercises 
are necessary, (b) pain medication, and (c) physiotherapy. All 
GPs in this study were instructed not to request an MR ex-
amination in this trial arm when the former treatment did not 
have satisfactory results but to refer the patient to an orthope-
dic surgeon. Patients in the MR group underwent MR imaging 
within 2 weeks after completing the first questionnaire in addi-
tion to usual care based on the aforementioned guidelines (15).
Intervention: MR Imaging
MR imaging was performed with a 1.5-T MR imager by using 
a dedicated knee coil at six different centers (one university 
hospital, four peripheral hospitals, and a private MR center 
with several locations in the Netherlands). Prior to the start of 
the study, three radiologists evaluated and approved all “acute 
knee” MR protocols used at each center. These protocols were 
optimized for each MR imager, were familiar to the radiolo-
gists in that particular center, and provided a good reflection 
of the factual diagnostics, as used in the Netherlands. All pro-
tocols included sequences in the sagittal, coronal, and trans-
verse planes, with at least one sequence with fat suppression 
and one gradient echo sequence targeted on cartilage damage.
Prior to the start of this study, two orthopedic surgeons defined 
positive MR findings that might need further assessment by an 
orthopedic surgeon (ie, trabecular fracture, complete rupture of a 
collateral ligament, meniscus tear, cruciate ligament rupture, full-
thickness cartilage defect). In the present study, we specifically in-
structed and trained 12 musculoskeletal radiologists, each with at 
least 10 year of experience. Referral advice was based on the pres-
ence of positive MR findings and was automatically derived from 
an encrypted Web-based standardized MR imaging knee report 
(19). The referring GP received a speech-based free-text report, as 
usual. In addition, radiologists were asked to conclude their MR 
report with the referral advice derived from the structured online 
MR report. These patients returned to their GP for the MR result 
and continued in primary care with treatment as described in the 
Dutch clinical guidelines (15), unless they were referred to an or-
thopedic surgeon, who would subsequently take over their care 
and treatment.
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Primary Outcome Measures: 
QALYs and Costs
We performed a cost-utility analysis 
from a healthcare and societal perspec-
tive with a 1-year time horizon, accord-
ing to the Consolidated Health Eco-
nomic Evaluation Reporting Standards 
(or CHEERS) (20). We used the three-
level EQ-5D questionnaire (Euroqol, 
Rotterdam, the Netherlands) to calcu-
late quality-adjusted life years (QALYs) 
as the area under the curve of the util-
ity scores measured over 12 months, 
according to the Dutch tariff (21,22). 
Scores were measured at baseline, 6 
weeks, and 3, 6, 9, and 12 months. 
Costs were evaluated by using self-
reported questionnaires at 3, 6, 9, and 
12 months, reflecting on the previous 3 
months. Healthcare costs included costs 
for GP visits, physiotherapy sessions, 
orthopedic surgeon visits, MR imag-
ing, conventional imaging, arthroscopy, 
hospital admission, and medication. 
Nonhealthcare costs included costs for 
work absenteeism, work presenteeism 
(reduced quality of work), unpaid work 
(groceries, housekeeping, children; 
calculated only over the differences 
between the two groups), housekeep-
ing, caregiving by the family, traveling, 
and medical aids, such as knee braces 
or crutches. Unit costs sources are pre-
sented in the Table and were mostly 
derived from the Dutch guideline for 
economic evaluation with standard ref-
erence prices in Euros at the 2015 price 
level, without discounting (23,24).
Statistical Analyses
All analyses were performed according to the intention-to-
treat principle. Missing data were corrected for possible se-
lective nonresponse by using multiple imputations with fully 
conditional specification and predictive mean matching (25). 
We imputed 100 data sets with four iterations by using the fol-
lowing predictors: randomization group, age, sex, body mass 
index, loss to follow-up, clinical scores (eg, Lysholm scores), 
and utilities. The Student t test was used to assess differences 
in mean QALYs, costs, and net benefits between the MR group 
and the usual care group. P , .05 indicated a significant differ-
ence. We expressed cost-effectiveness by using cost-effectiveness 
acceptability curves from both a healthcare perspective and a so-
cietal perspective. Depending on the willingness to pay (WTP) 
per QALY, the acceptability curves show the probability that 
MR imaging has a more favorable net benefit (NB = WTP 3 
QALYs2C), where C is costs, than does usual care. Addition-
ally, we plotted 400 bootstrap replicates of the average difference 
Figure 1: Flowchart shows patient allocation in this randomized controlled trial. GP = general 
practitioner, IQR = interquartile range.
in costs and effects in the incremental cost-effectiveness plane 
to express the uncertainty of our cost-effectiveness analysis. 
All analyses were performed by using statistical software (IBM 
SPSS, version 22.0; SPSS, Chicago, Ill).
Ancillary Analyses
Three secondary analyses were performed, two of which were 
purely in specific subgroups of patients. The first subgroup 
consisted of patients with a duration of knee symptoms of 4 
weeks or longer, since referral to an orthopedic surgeon in the 
1st weeks after knee trauma should have no effect on the treat-
ment course, as stated in the Dutch clinical guidelines (15). On 
the basis of these guidelines and with consensus in the project 
research group (GPs, radiologists, and orthopedic surgeons), 
we intended to include only those patients with persistent knee 
symptoms lasting 4 weeks or longer. However, during the start 
of the study, the participating GPs preferred to also include pa-
tients with a shorter duration of symptoms, since this was more 
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in keeping with daily practice. The second subgroup of patients 
also had knee symptoms for more than 4 weeks, and they were 
directly included during the first consultation by the GP. In the 
third and final ancillary analysis, which included all patients, 
we measured QALYs with the transformed Visual Analog Scale 
(VAS) of the EQ-5D questionnaire ranging from 0 (worst imag-




The GPs invited 836 patients to participate in this study, 356 
of whom could be included and randomized (Fig 1). Of the 
179 patients allocated to the MR imaging group, 174 underwent 
MR imaging. Three patients did not attend their MR imaging 
appointment, one patient was pregnant, and one did not un-
dergo MR imaging because of personal circumstances. Of the 
177 patients allocated to the usual care group, at least 10 un-
derwent MR imaging requested by the GP (responders’ data).
QALYs and Costs
No significant differences were found in mean QALYs over 
the 12-month follow-up period between the MR group and 
the usual care group (0.888 vs 0.899, P = .225) (Fig 2). There 
were significantly higher healthcare costs per patient in the MR 
group (€1109) than in the usual care group (€837) (mean dif-
ference, €273; 95% confidence interval: 0, 545) (Table). This 
difference was mainly based on higher costs of MR imaging and 
on insignificantly higher costs of physiotherapy and arthroscopy 






MR Imaging Group  
(n = 179)
Usual Care Group  
(n = 177)










GP visit 33 A 41 0.84 28 47 1.13 37 29 (220, 1)
Physical therapy sessions 33 A 60 10.58 349 55 8.52 281 68 (256, 192)
Orthopedic surgeon visit 91 A 44 1.20 109 41 1.20 109 0 (237, 37)
Other medical specialist visit* 91 A 9 0.19 17 8 0.17 16 2 (215, 18)
Company doctor visit 100 B 12 0.26 26 12 0.30 30 24 (226, 19)
Nursing help (per hour) 73/h A 0 0 0 0 0.22 16 16 (248, 15)
Conventional imaging 42 B 32 0.34 14 35 0.38 16 22 (27, 3)
MR imaging 215 A 100 1.09 235 37 0.44 94 140 (115, 166)
Arthroscopy 950 B 22 0.25 235 16 0.18 166 69 (231, 168)
Hospital admission
 Day care 276 A 23 0.30 82 15 0.18 50 31 (22, 65)
 Clinical (including night care) 476 A 2 0.02 12 3 0.04 18 26 (226, 14)
Intra-articular injections 4 C 4 0.04 0 8 0.11 0 0 (21, 0)
Medication … C 34 NA 2 34 NA 3 21 (24, 2)
Total healthcare cost … … … … 1109 … … 837 273 (0, 545)
Absenteeism† 35/h A, D 54 10.3 2520 49 7.8 2046 474 (2498, 1446)
Presenteeism, reduced quantity‡ 35/h A, D 38 4% 1872 37 4% 1856 17 (2907, 940)
Unpaid self-produced labor§ 214/h A 100 1269 290 100 1256 93 2184 (22756, 2389)
Housekeeping help 20/h A 4 55 55 2 12 12 43 (214, 100)
Help by family 14/h A 9 7.3 103 14 10.5 148 245 (2170, 79)
Travel costs … A 100 NA 25 75 NA 19 6 (0, 12)
Cost of medical aids|| … D 56 NA 41 58 NA 50 29 (224, 6)
Total nonhealthcare cost … … … … 4526 … … 4224 302 (22659, 3262)
Total cost … … … … 5635 … … 5061 574 (22462, 3611)
Note.—Data in parentheses are 95% confidence intervals. A = guideline for economic evaluations (The Dutch National Healthcare Insti-
tute), updated September 2015, B = our own data, C = www.medicijnkosten.nl, D = self-reported patient data.
* Other medical specialists, including surgeons, rheumatologists, revalidation specialists, neurologists.
† Friction method: maximum of 85 absence days for a job with 5 workdays a week (ie, maximum of 12 weeks absence, self-reported job 
hours and days per week, €34.75 per working hour); 90% of the patients had a paid job with a mean of 4.4 days and 33 hours per week.
‡ Reduced quantity ranging from 0% (normal production quantity) to 100% (produced nothing). Expressed as the mean percentage 
reduced quantity over 12 months.
§ Unpaid labor includes hours spent on housekeeping, groceries, odd jobs, volunteering, children, and education. Only the difference 
between groups was calculated.
|| Medical aids includes costs for braces, compresses, inlays, crutches, and salves.
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Figure 2: Graph shows patients’ utility scores and mean quality-
adjusted life years (QALY) over the 12 months of follow-up. QALY 
was measured as the area under the curve over 12 months with the 
EuroQol 5 dimensions (EQ-5D) utility score (Dutch tariff) ranging from 
20.329 (worst health status) to 1.000 (best health status).
in the MR group. In the MR group, 22% of patients under-
went arthroscopy compared with 16% of patients in the usual 
care group (P = .150). Furthermore, insignificant higher non-
healthcare costs were observed in the MR group (mean differ-
ence, €302; 95% confidence interval: 22659, 3262). These 
higher nonhealthcare costs were mainly based on higher costs 
for work absenteeism in the MR group, with a mean of 10.3 
absent workdays in the MR group compared with 7.8 absent 
workdays in the usual care group (P = .188).
Cost-effectiveness
From a healthcare perspective, the probability that MR imag-
ing is a cost-effective alternative to usual care ranged from 3% 
for €0 WTP per QALY (ie, when only costs count) to 8% for 
€80 000 WTP/QALY (ie, the unofficial upper bound threshold 
for cost-effectiveness in the Netherlands) (Fig 3). From a soci-
etal perspective, because of the larger uncertainty of the cost 
difference, the probability starts higher at 36% for €0 WTP/
QALY and then decreases to 21% for €80 000 WTP/QALY. 
The accompanying scatter plot (Fig 4) shows the majority of 
the bootstrap replicates in the northwest quadrant (91% for 
the healthcare perspective, 61% for the societal perspective), 
meaning overall higher costs for lower QALYs.
Ancillary Analyses
In Appendix E1 (online), we present the figures and tables for 
ancillary analyses. Most analyses enabled us to confirm the eco-
nomic preference for usual care. Only the second exploratory 
analysis in the subgroup of patients directly included by the GP 
and with a duration of symptoms of 4 weeks or more (n = 94) 
showed a probability of MR imaging being cost-effective 
compared with usual care ranging from 75% for €0 WTP/
QALY to 83% for €20 000 WTP/QALY from a healthcare 
perspective. From a societal perspective, this was 58% and 
62%, respectively. However, caution is required when inter-
preting these findings, as there were only 94 patients in this 
subgroup, implying considerable uncertainty.
Discussion
In patients aged 18–45 years with a traumatic knee symptoms 
seeking medical attention in a primary care setting, no differ-
ences in mean QALYS over the 12-month follow-up period 
were found between the MR group and the usual care group. 
The MR group had significantly higher healthcare costs, mainly 
because of more physiotherapy sessions and more arthros-
copies, in addition to the study-initiated MR examinations. 
Furthermore, in the MR group, there was no reduction in the 
referral rate to an orthopedic surgeon. Total costs unrelated to 
healthcare were also slightly higher (this difference was not sig-
nificant) in the MR group based on more work absenteeism. 
From the cost-utility analyses, we concluded that referral for 
early MR imaging by the GP is unlikely to be cost-effective 
compared with usual care in patients aged 18–45 years with 
traumatic knee symptoms.
In the United Kingdom, a randomized controlled trial was 
performed on the cost-effectiveness of MR imaging in a sub-
group of patients suspected of having an internal derangement 
who were referred to an orthopedic surgeon (10). Patients were 
randomly assigned to (a) imaging with a provisional orthope-
dic appointment or (b) orthopedic referral without prior MR 
imaging. The authors included 553 patients and analyzed 386 
complete cases; no significant differences were found in mean 
QALYs over 24 months between these two groups (26). The ac-
companying efficiency study showed that patients in the MR 
group also reported no significant improvement over time 
measured with the Short Form 36-item physical functioning 
scale in contrast to the patients in the direct orthopedic referral 
group (27). In the cost-effectiveness study, only healthcare costs 
were considered and were higher in the MR group. In the MR 
group, 40% underwent arthroscopy compared with 28% in the 
orthopedic group, with more subsequent work absenteeism in 
the MR group; our results are in line with these findings (10). 
On the basis of an insignificant increase in QALYs in the MR 
group of 1.444 compared with 1.393 in the orthopedic referral 
group, the authors concluded that MR imaging in primary care 
was 80% likely to be cost-effective in patients presenting with 
knee symptoms, with an incremental cost-effectiveness ratio of 
£5000–£6,000 per QALY. However, the authors recommend 
caution when interpreting their findings because private costs 
and productivity losses were not considered, 30% of the cases 
were excluded because of missing data, and there was a potential 
recall bias with the last questionnaire reflecting on the past 12 
months.
Another randomized controlled trial with cost-effectiveness 
analysis included 120 patients who presented to the emergency 
department with knee pain and who were referred to an ortho-
pedic surgeon (28). All patients underwent MR imaging; how-
ever, prior to the MR examination, patients were randomized 
and only half of the cohort was informed about the MR result. 
van Oudenaarde et al
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The other half, including the involved orthopedic surgeon, was 
blinded to the MR result (ie, the no MR imaging group). Over-
all, higher utilities with significantly lower costs were observed 
in the no MR imaging group (arthroscopy rate was 24% in this 
group and 30% in the MR imaging group), and these findings 
were in line with our results. Also, in patients with lower back 
pain, routine diagnostic imaging led to worse or, at best, unim-
proved self-reported outcomes, supporting the robustness of our 
findings (29).
To our knowledge, this study is the first to thoroughly as-
sess the cost-effectiveness of MR imaging in primary care. With 
a multicenter design involving 150 GPs and six different MR 
centers, we compiled a sample of patients aged 18–45 years with 
traumatic knee symptoms, reflecting (to a large extent) daily MR 
imaging practice. We evaluated a wide range of associated costs, 
including the costs for productivity losses. Furthermore, we ana-
lyzed all cases according to the intention-to-treat principle, with-
out excluding cases for missing data. Possible attri-
tion bias was handled with multiple imputations.
Unfortunately, difficulties were encountered in 
including a sufficient number of patients, despite 
our efforts to regularly remind GPs via telephone 
calls, office visits, and newsletters. The sample size 
calculation in this study was based on the primary 
endpoint, which was to show noninferiority of 
knee-related daily function as measured with the 
Lysholm Knee Scoring Scale. The current study was 
developed to address secondary objectives of QA-
LYs and costs; any observed null findings could be 
attributed to a lack of power. Eventually, the sample 
size was decreased from 520 to 356 patients, and 
invitation letters were sent to eligible patients who 
were not directly invited during the first consulta-
tion. The effect of this intervention was reviewed in 
the ancillary explorative analyses bu using specific 
subgroups. These analyses were not predefined and 
have a low statistical power, with a small 
number of patients in each subgroup. 
Data on quality of life and costs were 
collected every 3 months, minimizing 
recall bias. Bias could have been intro-
duced by the unblinded randomization. 
For patients who were satisfied with the 
randomization to MR imaging, this 
could hypothetically result in a higher 
quality of life in the MR imaging group 
that was not detected. We believe the un-
blinded randomization had no influence 
on the reported costs.
Furthermore, no data were collected 
on surgery for anterior cruciate ligament 
reconstruction, and we evaluated only 
the performed arthroscopies. However, 
this may not have affected our main 
results, because this probably concerns 
only a few patients evenly distributed 
over both groups, since most patients 
Figure 4: Graph shows incremental cost-effectiveness plane from a societal and healthcare 
perspective using 400 bootstrap replicates for each. QALY = quality-adjusted life year.
Figure 3: Graph shows probability that MR imaging in primary care is cost-effec-
tive compared with usual care in patients with traumatic knee symptoms. QALY =  
quality-adjusted life year.
with an anterior cruciate ligament rupture do not undergo re-
constructive surgery (30).
On the basis of the present results, referral by the GP for MR 
imaging was not cost-effective in patients aged 18–45 years with 
traumatic knee symptoms. MR imaging led to more healthcare 
costs, without improving health outcomes. Although our explor-
atory analyses indicated that a subgroup of patients might exist 
in whom MR imaging could be cost-effective, the characteristics 
of this subgroup need to be evaluated in a future study. For the 
moment, usual care as described in the Dutch general practice 
guidelines (15) without referral for MR imaging and with referral 
to an orthopedic surgeon in patients with persistent knee symp-
toms should be the guideline of choice. Our results can also be 
applied to other healthcare systems in which healthcare provid-
ers other than orthopedic surgeons are involved in the primary 
care and diagnostic work-up of patients with symptoms after a 
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traumatic knee injury. Not to request an MR examination might 
be challenging in the current climate of defensive medicine, in 
which patients are demanding and healthcare providers have a 
limited amount of time. With the presented results, we hope to 
support both patients and healthcare providers in the primary 
evidence-based care of patients with traumatic knee symptoms.
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